|
|
Lauren UzdienskiResearch AssociateMs. Uzdienski's primary responsibilities are to generate content for the HealthpointCapital blog and report pipeline, edit and market research products, manage content for HealthpointCapital's industry database and oversee the company's presence at conferences and industry events. She joins HealthpointCapital from the publishing industry. B.A., New York University
Recent Articles by Lauren Uzdienski
How Teeth and Bones Can Treat Hearing Loss MAY 15, 2012Though a bit outside our typical musculoskeletal focus, this morning's funding announcement from Sonitus Medical has highlighted the role of hard tissue in providing solutions for hearing loss. more Musculoskeletal News Roundup 10-May-12 MAY 10, 2012ATEC, ANIK, BMTI, MAKO, TRNX, TSON report 1Q ... OrthoSensor raises $15M ... Internal Fixation Systems announces distribution agreement with Intelligent Orthopaedics ... Seikagaku announces marketing agreement with Kaken for lumbar disc herniation treatment ... Bioventus officially launched more Clinical Roundup May 2012 MAY 10, 2012Use of fibrin sealant QUIXIL in TKAs ... The accuracy of imaging in spine surgery ... ACL revision data from Denmark ... Ankle surgery and weight loss ... More surgeons working for hospitals more User Fee Legislation Making Its Way through Congress MAY 9, 2012Yesterday a House subcommittee unanimously voted to pass the user fee re-authorization for FY2013. The full Energy and Commerce Committee will mark up the bill on Thursday, with the intention of moving the bill to the floor quickly and passing it before the Supreme Court rules on healthcare reform in June. In the Senate, the Health, Education, Labor and Pensions Committee has approved the bill, and the legislation is expected to reach a floor vote next week. more Royal DSM to Acquire Kensey Nash for $337 Million MAY 3, 2012Kensey Nash has entered into a definitive agreement to be acquired by Royal DSM for $38.50 per share in cash, or about $337 million in total. The offer represents a 33% premium to yesterday's close and about a 4.0x trailing 12-month revenue multiple. more |
|
 |